You are viewing the site in preview mode
Skip to main content
|
Predictors
|
Event/p-M
|
IR/100P-Y
|
CIRR(95%CI)
|
p.value
|
AIRR(95%CI)
|
|---|
|
Over all
|
39/9766
|
4.79
|
–
|
–
|
–
|
|
Program
|
|
UTT
|
6/ 3417
|
2.10
|
0.33 (0.11–0.81)
|
0.003
|
0.25 (0.08–0.70)*
|
|
Differed
|
33/6349
|
6.23
|
1
| |
1
|
|
Age
|
–
|
–
|
1.01 (0.97–1.04)
|
0.622
|
–
|
|
Sex
|
|
Male
|
14/3134
|
5.36
|
1.18 (0.56–2.37)
|
0.230
|
1.33 (0.64–2.75)
|
|
Female
|
25/6632
|
4.52
|
1
| |
1
|
|
Residence
|
|
Rural
|
26/ 4094
|
7.6
|
2.77 (1.42–5.38)
|
0.001
|
1.58 (0.82–3.05)
|
|
Urban
|
13/5672
|
2.75
|
1
| | |
|
Employment
|
|
Employed
|
21/6999
|
3.60
|
1
| |
1
|
|
Unemployed
|
18/2767
|
7.80
|
2.16 (1.34–5.10)
|
0.001
|
2.2 (0.82–4.54)
|
|
Marital status
|
|
Married
|
23/4920
|
5.60
|
1.41 (0.71–2.86)
|
0.14
|
1.73 (0.88–3.40)
|
|
Unmarried
|
16/4846
|
3.96
|
1
| |
1
|
|
Educational status
|
|
Illiterate
|
16/3680
|
5.22
|
1.15 (0.56–2.27)
|
0.33
| |
|
Literate
|
23/ 6086
|
4.53
|
1
| | |
|
Weight
|
–
|
–
|
0.97 (0.94–1.00)
|
0.110
|
0.97 (0.94–1.01)
|
|
WHO stage
|
|
Stage I/II
|
9/3600
|
3.00
|
0.51 (0.26–0.96)
|
0.018
|
0.70 (0.61–0.94)*
|
|
Stage III/IV
|
30/6166
|
5.84
|
1
| |
1
|
|
IPT
|
|
Yes
|
15/6800
|
2.64
|
0.27 (0.18–0.56)
|
0.001
|
0.35 (0.22–0.48)*
|
|
No
|
24/2966
|
9.71
|
1
| |
1
|
|
Treatment failure
|
|
Yes
|
5/ 422
|
14.2
|
3.25 (1.10–8.36)
|
0.015
|
5.80 (1.93–8.46)*
|
|
No
|
34/ 9344
|
4.37
|
1
| |
1
|
|
Base line CD4 count
|
–
|
–
|
0.99 (0.98–1.00)
|
0.050
|
0.96(.94–0.99)*
|
- *AIRR Adjusted Incidence Rate Ratio, *IRR Incidence Rate Ratio, *CIRR Crude Incidence Rate Ratio
